🇮🇹 Italy Country × Condition
prostate cancer Clinical Trials in Italy
Active clinical trials for prostate cancer with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 3, Phase 1 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇮🇹 Italy
Active Trials in Italy (5)
NCT03819101 Phase 3
Recruiting
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
Enrollment
1,210 pts
Country
🇮🇹 Italy
Gustave Roussy, Cancer Campus, Gran...
View Trial → NCT06292897
Recruiting
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression
Enrollment
25 pts
Country
🇮🇹 Italy
Fondazione IRCCS Ca' Granda, Ospeda...
View Trial → NCT06652607
Recruiting
PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer
Enrollment
152 pts
Country
🇮🇹 Italy
Fondazione Policlinico Universitari...
View Trial → NCT06331013
Recruiting
CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr
Enrollment
60 pts
Country
🇮🇹 Italy
European Institute of Oncology
View Trial → NCT07600554 Phase 1
Recruiting
A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer
Enrollment
20 pts
Country
🇮🇹 Italy
Philogen S.p.A.
View Trial → Frequently Asked Questions
How many prostate cancer clinical trials are active in Italy?
There are currently 5 active clinical trials for prostate cancer with sites in Italy, of which 5 are actively recruiting patients.
How can I join a prostate cancer clinical trial in Italy?
To join a prostate cancer clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are prostate cancer trials in Italy?
Active prostate cancer trials in Italy span Phase 3, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology